ArticleInternational journal of medical sciences2025

Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan.

Li-Nien Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.